Edgestream Partners, L.P.

Position in ALKS — Alkermes plc.

CIK 1535061 Princeton, NJ

Position in ALKS

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$1,867,927

-$6,282,619 QoQ

Shares Held

52,826

-81.9% QoQ

Ownership

0.032%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

16 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Edgestream Partners, L.P. holds $28,592,165 across 5 Drug Manufacturers - Specialty & Generic names. ALKS ranks #5 (6.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	77,506	$9,161,984
2	NBIX	Neurocrine Biosciences Inc	50,587	$6,664,331
3	PBH	Prestige Consumer Healthcare Inc.	108,814	$6,449,405
4	VTRS	Viatris Inc	329,276	$4,448,518
5	ALKS	Alkermes plc. This page	52,826	$1,867,927

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,867,927	52,826	-81.9%	Shares	Sole	2026-05-18
2025-12-31	$8,150,546	291,299	+12.3%	Shares	Sole	2026-02-13
2025-09-30	$7,782,330	259,411	+251.0%	Shares	Sole	2025-11-12
2025-06-30	$2,114,221	73,898	-33.0%	Shares	Sole	2025-08-13
2025-03-31	$3,640,256	110,244	+103.8%	Shares	Sole	2025-05-02
2024-12-31	$1,556,088	54,106	-80.0%	Shares	Sole	2025-02-07
2024-09-30	$7,576,081	270,671	+218.4%	Shares	Sole	2024-11-14
2024-06-30	$2,049,054	85,023	+6.8%	Shares	Sole	2024-08-09
2024-03-31	$2,155,015	79,609	+206.1%	Shares	Sole	2024-05-10
2023-12-31	$721,489	26,009	-23.0%	Shares	Sole	2024-02-14
2023-09-30	$945,617	33,760	+146.8%	Shares	Sole	2023-11-15
2023-06-30	$428,184	13,680	-81.4%	Shares	Sole	2023-08-10
2022-12-31	$1,923,559	73,615	+143.4%	Shares	Sole	2023-02-13
2022-09-30	$675,326	30,243	-56.0%	Shares	Sole	2022-11-14
2022-03-31	$1,807,128	68,686	-66.7%	Shares	Sole	2022-05-13
2021-12-31	$4,801,050	206,408	—	Shares	Sole	2022-02-15
No filing history on record for this holder in this stock.